Voloridge Investment Management’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$354K	Buy	+17,656	New	+$354K	﹤0.01%	1101
2024 Q4	–	Sell	-17,320	Closed	-$442K	–	1233
2024 Q3	$442K	Buy	17,320 +5,665	+49%	+$145K	﹤0.01%	1091
2024 Q2	$272K	Buy	+11,655	New	+$272K	﹤0.01%	1155